Wikipedia -WSS

Wikipedia

author：entertainment 2025-09-30 19:25:53 - browse：544

Who polices algorithms? How would you name the first approved CRISPR medicine? And what pairs well with a biotech downturn?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Casey Ross joins us to tell the bombshell story of how the nation’s largest health insurer used a computer algorithm to deny patient care and boost its profitability. Then, biotech veteran Michael Gilman calls in to offer a behind-the-scenes peek at what it’s like to be a startup CEO in this economic downturn — and which cocktail recipes help make it bearable. We also discuss a pioneering approval for a genome-editing medicine.

For more on what we cover, here’s the UnitedHealth story; here’s more on the CRISPR approval; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Researchers tackle phage therapy hurdles for wider adoption

focus

WSS

Arc Institute generative AI designs new CRISPR systems

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

Medicare Advantage enrollment grows 7.1% to 33.4 million people

Flagship Pioneering startup Sonata Therapeutics lays off 21

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

focus

Wikipedia

focus

Peter Hotez and the public health issue of online harassment

Researchers tackle phage therapy hurdles for wider adoption

New air purifier tech could be key to improving indoor air quality

Glen Campbell's doctor discusses his public struggle with Alzheimer's

At least 13 dead in Texas as scorching temps continue

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Criminal prosecution for violating HIPAA: an emerging threat

DIEP, the 'gold standard' of breast reconstruction, is under threat

Glen Campbell's doctor discusses his public struggle with Alzheimer's

hotspot

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

MD Anderson's Padmanee Sharma responds to research credit suit

FDA warns medical device makers about rise in fabricated data

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

Solving academic medical centers' existential crisis

explore

hotspot

focus

Wikipedia